This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Gmbh. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Georg Kottirsch: Innovator in Antithrombotic Agents
Introduction
Georg Kottirsch is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic agents. His work focuses on innovative solutions to combat thrombosis, a serious medical condition.
Latest Patents
Kottirsch holds a patent for "Pseudopeptide isosteres of gly-asp and their use as antithrombic agents." This patent describes pseudopeptides of a specific formula, which can be utilized in both free and salt forms. The invention aims to provide effective prophylactic and acute treatment options for thrombosis.
Career Highlights
Georg Kottirsch is currently employed at Sandoz GmbH, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative medical solutions. Kottirsch's dedication to advancing healthcare through his inventions is commendable.
Collaborations
Kottirsch collaborates with Rainer Metternich, a fellow professional in the field. Their partnership enhances the research and development process, leading to more effective solutions in the pharmaceutical industry.
Conclusion
Georg Kottirsch's contributions to the field of antithrombotic agents exemplify the impact of innovation in healthcare. His patent and ongoing work at Sandoz GmbH highlight the importance of research in developing effective treatments for serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile